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INTRODUCTION
Angiosarcomas are vascular endothelium-derived 
malignant tumors that arise in blood vessel walls, and 
account for only 2 .3％ of all soft tissue sarcomas in 
adults. Angiosarcomas mainly arise in the skin, breast, 
soft tissues, bone, and viscera, with the skin and breast 
as the most common site of occurrence for primary an-
giosarcoma1）. Primary hepatic angiosarcoma（PHA）is 
rare and accounts for less than 5％ of all angiosarco-
mas1,2）. We report here in a rare case of PHA in which 
the patient presented with a chief complaint of hemop-
tysis.
CASE REPORT
A 61-year-old man was evaluated by the Depart-
ment of Gastroenterology at Dokkyo Medical Universi-
ty Koshigaya Hospital for a chief complaint of right-
sided abdominal pain. He had a past history of 
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SUMMARY
Angiosarcoma is a vascular endothelium-derived malignant tumor that arises in blood vessel walls, ac-
counting for only 2.3％ of soft tissue sarcomas in adults. Primary hepatic angiosarcoma（PHA）is rare, com-
prising＜5％ of all angiosarcomas. We report a case of PHA in a 61-year-old man evaluated by another clin-
ic around our hospital for a chief complaint of hemoptysis in May 2012. Chest computed tomography（CT）
showed abnormal shadows in bilateral lung fields, so he was referred to Department of Respiratory Medi-
cine at our hospital in late July. However, no definitive diagnosis was not made, even after bronchoscopy. In 
mid-August, he presented to the outpatient clinic of the respiratory department with a chief complaint of 
right-sided abdominal pain. Abdominal CT showed a liver lesion, and he was urgently admitted to our de-
partment. Initial physical examination was unremarkable except for palpable liver in the right hypochondri-
um. Tumor markers for liver and biliary cancers were all within normal limits, and negative results were 
obtained for hepatitis B and C virus. CT, ultrasonography, and（MRI）identified a large lesion replacing the 
right hepatic lobe and medial segment of the left hepatic lobe. Hemangioma or hepatic angiosarcoma was 
suspected, accompanied by intraperitoneal rupture. Transcatheter arterial embolization was attempted, but 
had to be discontinued, and the patient died from hemorrhagic shock due to tumor rupture after onset of 
abdominal pain. The PHA which assumes hemoptysis primary symptom is extremely rare, and by reports 
for the past ten years searched using PubMed, this is the second report in the world.
Case Report
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Chest CT showed ground glass opacities with indis-
tinct borders bilaterally, predominantly in the lower 
lung fields（Fig. 1）. Plain abdominal CT showed a 15×
12-cm lesion that had replaced the right hepatic lobe 
and medial segment of the left hepatic lobe（Fig. 2a）. 
The tumor showed slightly lower density than normal 
liver parenchyma, with faint high-density areas interi-
orly. The tumor increased in comparison with the last 
CT clearly. The tumor interior showed patchy en-
hancement early in the arterial phase（Fig. 2b）, and 
heterogeous faint enhancement in the portal/equilibri-
um phase（Fig. 2 c）. Besides the tumor described 
appendicitis at 9 years old and gastric ulcer at 57 years 
old. The family history was positive for diabetes in 
both parents. He had been smoking 25 cigarettes/day 
for 40 years, did not drink alcohol, and was employed 
as a high school teacher.
The patient was evaluated by another clinic around 
our hospital for a chief complaint of hemoptysis in May 
2012. Chest computed tomography（CT）showed ab-
normal shadows bilaterally in the lung fields, so he was 
referred to Department of Respiratory Medicine at our 
hospital in late July. It was not shown in a figure for an 
indistinct image, but about 10 cm tumors were found in 
liver at this time. However, no definitive diagnosis was 
made even after bronchoscopy. In mid-August, he pre-
sented to the outpatient clinic of the Department of 
Respiratory Medicine with a chief complaint of right-
sided abdominal pain, and abdominal CT showed a le-
sion in the liver. He was therefore urgently admitted to 
our department.
Initial physical examination was unremarkable ex-
cept for a palpable liver 3 fingerbreadths in the right 
hypochondriac region. Table 1 shows blood test results 
from the initial physical examination at our depart-
ment. Levels of LDH, g-GTP, WBC count, CRP, and co-
agulation/fibrinolytic factors were all elevated. Tumor 
markers for liver cancer and biliary cancer, including 
AFP, PIVKA-II, CEA, and CA19-9 were all within 
normal limits, and negative results were obtained for 
HBs antigen and HCV antibody.
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Table 1　Laboratory data
Blood chemistry Hematological analysis Viral markers
AST 50 IU/l WBC 16700 /ml HBs Ag （−）
ALT 41 IU/l RBC 4.01 ×106/l HBc Ab （−）
ALP 309 IU/l Hgb 13 g/dl HCV Ab （−）
LDH 797 IU/l Plt 14 ×104/l
GGT 221 IU/l PT 96 ％ Tumor markers
T-Bil 1.03 mg/dl fibrinogen 398 mg/dl AFP 5.9 ng/ml
D-Bil 0.15 mg/dl D-dimer 53.44 mg/ml PIVKA-II 18 mAU/ml
TP 7.4 g/dl FDP 57.2 mg/ml CEA 3.3 ng/ml
Na 141 mEq/l IgG 970 mg/dl CA19-9 7.8 U/ml
K 5.2 mEq/l IgM 257 mg/dl
Alb 4.42 g/dl IgA 18 mg/dl
BUN 22 mg/dl
Cre 1.1 mg/dl
CRP 2.08 mg/dl
NH3 23 mmol/l
Figure 1　Plain chest computed tomography（CT）
Plain chest CT shows ground glass opacities with 
indistinct borders predominantly in the lower lung 
fields bilaterally.
Primary hepatic angiosarcoma
es in the anterior segment of the right hepatic lobe and 
countless cotton wool-like areas corresponding to the 
giant tumor in the liver S6（Fig. 3）.
Based on these imaging findings, hepatic tumor was 
diagnosed and suspected as either hepatic hemangioma 
or hepatic angiosarcoma, with accompanying intraperi-
toneal rupture. Transcatheter arterial embolization
（TAE）was attempted on the 11th day after admission, 
but had to be discontinued due to worsening respirato-
ry status. Further TAE was scheduled for a later time, 
but during systemic management, the patient died 
from hemorrhagic shock due to tumor rupture after 
onset of abdominal pain on the 14th day after admis-
sion. Autopsy was performed.
Figure 4 shows the excised liver at autopsy. The liv-
er was enlarged, weighing 2780 g, and a soft, dark-red 
tumor lesion measuring about 19.5×16.5 cm was pres-
ent, mainly involving the anterior segment of the right 
lobe from the surface. In addition, a fissure in the he-
patic capsule was observed, measuring about 7 . 0×
above, multiple tumors with ring-like enhancement 
were evident in both hepatic lobes, and accumulation of 
hyperdense fluid surrounded the liver.
Abdominal ultrasonography showed the neoplastic 
lesion which almost accounted for the whole of liver 
right lobe.
Abdominal magnetic resonance imaging（MRI）
showed tumor replacing the anterior segment of the 
right hepatic lobe and medial segment of the left he-
patic lobe. T1-weighted imaging showed signal hypoin-
tensity of the tumor with a septum-like structure in 
the interior. T2-weighted imaging showed signal hy-
perintensity throughout. Diffusion-weighted imaging 
revealed a mixture of high and low signal intensity.
Angiography was performed for further evaluation. 
CT during transarterial portography showed the tu-
mor lesion as a large perfusion defect in liver S6. CT 
during hepatic arteriography showed enhancement of 
the entire tumor from the margins. Digital-subtraction 
angiography（DSA）showed marked dilation of branch-
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Figure 2　Abdominal CT
Plain abdominal CT shows a 15×12-cm tumor replacing 
the right hepatic lobe and medial segment of the left 
hepatic lobe. a）The tumor shows slightly lower density 
than the normal liver parenchyma, with faint high-
density areas interiorly. b）On a dynamic study, the 
tumor interior showed patchy enhancement early in the 
arterial phase（b）, and heterogenous faint enhancement 
in the portal/equilibrium phase（c）.
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phic cells and atypical round cells among the vascular 
endothelial cells（Fig. 7a）. Immunohistological staining 
of these cells yielded positive results for factor VIII and 
CD34（Fig. 7b）. These lesions were diagnosed as lung 
metastases from hepatic angiosarcoma.
DISCUSSION
PHA is more common in men, and the mean age of 
patients with PHA is 59 years3）. The 50 cases in our 
survey ranged in age from 29 to 81 years, with a mean 
age of 58.2 years. These 50 cases included 39 men（78
％）and 11 women（22％）. Initial symptoms include 
abdominal pain in 24（48％）, malaise and anorexia in 
11（22％）, jaundice in 3（6％）, fever in 2（4％）, hemop-
tysis in 1（2％）, and anemia in 1（2％）, while 8 patients
（16％）were asymptomatic. The cause of abdominal 
pain is usually intraperitoneal rupture of the PHA, and 
intraperitoneal hemorrhage has been reported in 
15-27％ of cases of PHA4,13）. Among the 50 patients 
with PHA in our survey, 13（26％）had intraperitoneal 
hemorrhage.
PHA may be difficult to diagnose, with some cases, 
as in our patient, diagnosed on autopsy12,14）. In addition, 
specific tumor markers for PHA have yet to be identi-
fied, and levels of AFP, CEA, and CA19-9 have been 
within normal limits, or only slightly elevated, in the 
reported cases. From a morphological perspective, 
PHA occurs as multiple nodules, dominant masses, or a 
4 .5 cm in the posterior segment of the right hepatic 
lobe（lateral S6）and showing adherent blood clots 
around this site. About 2700 ml of blood, together with 
blood clots, was seen in the peritoneal cavity at autop-
sy, due to intraperitoneal hemorrhage because of lesion 
rupture.
Figure 5 shows microscopic images of the liver. His-
tologically, low magnification showed dilation of various 
sized blood vessels, with partial sloughing, hemorrhage, 
and degeneration of blood vessel walls（Fig. 5a）. The 
other nodular lesions showed similar findings. High 
magnification showed a high nucleus/cytoplasm ratio, 
with proliferation of large polymorphic cells and atypi-
cal spindle cells and round cells predominantly in the 
vascular lumens（Fig. 5b）. Hepatic angiosarcoma was 
suspected based on these findings. Immunohistological 
staining yielded negative results for pan-cytokeratin 
markers（AE1/AE3）, and epithelial tumor was ruled 
out（Fig. 5c）. Findings were positive for both factor 
VIII and CD34 as vascular endothelial cell markers
（Fig. 5d）. These immunohistological findings confirmed 
the hepatic tumor as angiosarcoma.
Figure 6 shows the excised right lung. Dark-red 
nodular lesions measuring about 12×11 mm and about 
8×5 mm were present in the right lung lower lobe. 
The histological appearance was similar to the liver le-
sions, including hemorrhage, proliferation of various 
sized blood vessels, and proliferation of large polymor-
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Figure 4　Liver excised at autopsy
The liver is enlarged, weighing 2780 g, and a dark red 
tumor lesion measuring about 19.5×16.5 cm is present 
mainly in liver segment 6.
Figure 3　Digital-subtraction angiography（DSA）
DSA shows countless cotton wool-like areas corresponding 
to the giant tumor in liver segment 5.
Primary hepatic angiosarcoma
diffusely infiltrating lesion, and exhibits a spectrum of 
appearances on CT or MRI15）. Abdominal contrast-en-
hanced ultrasonography may also be useful 11）, but is 
not commonly performed. Liver biopsy, which is re-
quired for histological diagnosis, is not currently rec-
ommended because of an increased risk of hemor-
rhage5,6 ,12 ,14）. Diagnosis is currently based on imaging 
findings showing a rapidly enlarging hemangioma-like 
tumor, in which case PHA should be strongly suspect-
ed. Moreover, the risk of spontaneous rupture of he-
patic hemangioma is small, estimated as less than 1％. 
Hemorrhage from a hepatic vascular tumor may thus 
suggest a diagnosis of angiosarcoma7）.
Hemoptysis as the initial symptom in patients with 
PHA is rare, having only been reported once previous-
ly7）, and our patient is the second such case to be re-
ported. Our patient was a high school teacher, and al-
though he had a history of smoking, previous chest X-
rays during medical check-ups had shown no 
abnormalities. The patient only developed his main 
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Figure 5　Histological findings of the liver
a）Histologically, low magnification shows dilation of various sized blood vessels, with partial sloughing, 
hemorrhage, and degeneration of blood vessel walls. b）High magnification shows a high nucleus/cytoplasm 
ratio, with proliferation of large polymorphic cells and atypical spindle cells and round cells predominantly in 
the vascular lumens. c）Immunohistological staining showed negative results for pan-cytokeratin markers
（AE1/AE3）. d）Findings were positive for both factor VIII and CD34 as vascular endothelial cell markers.
Figure 6　Right lung excised at autopsy
Dark red nodular lesions measuring about 12×11 mm and 
about 8×5 mm are present in the right lung lower lobe.
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complaint of hemoptysis in May 2012 , at which time 
abnormal chest shadows were noted. Subsequently, the 
patient experienced abdominal pain due to intraperito-
neal hemorrhage of the PHA within about 3 months, 
and died 14 days after the onset of abdominal pain. The 
clinical course was thus rapid.
Our patient had not undergone abdominal imaging 
studies previously, but the tumor was large（15 cm）at 
the time of diagnosis, and is thought to have shown 
rapid growth based on the clinical history. Among the 
50 cases that we surveyed, survival time ranged from 
3 days to 40 months among the 35 cases for which out-
comes were documented,（mean survival time, 11 .1 
months）. However, most patients with PHA die within 
6 months after diagnosis16）. The prognosis differs sig-
nificantly between patients without and with organ 
metastases（9 months vs. 3 months, p＝0.172）, probably 
due to increased treatment options in patients without 
metastases8）.
Because PHA is a rare disease with very rapid pro-
gression, systematic treatments have yet to be estab-
lished. The first option for treatment after definitive 
diagnosis is usually surgical resection. Duan et al. re-
ported a median survival time of 41 months（23-
84 months）in 5 patients who underwent liver resec-
tion1 0）. Improved prognosis with postoperative 
chemotherapy or the addition of transarterial chemo-
embolization（TACE）of the liver has also been re-
ported6,9）. Although chemotherapy has been tried for 
unresectable cases, few reports have been made. Kim 
et al. described a median survival time of 86 days
（range, 8-439 days）in 4 patients with unresectable 
PHA treated using chemotherapy7）. Transcatheter ar-
terial embolization of the liver for intraperitoneal hem-
orrhage of PHA, and TACE to control hemorrhage, 
was reported as effective, but did not improve progno-
sis 4,8）. Unfortunately, TACE was not performed in our 
case, but even if it had been, prognosis would most 
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Figure 7　Histological findings of the right lung
a）Histological appearance of the lung sample was similar to that of the liver lesions, including 
hemorrhage, proliferation of various sized blood vessels, and proliferation of large polymorphic 
cells and atypical round cells among the vascular endothelial cells. b）Immunohistological staining 
of these cells was also positive for factor VIII and CD34. These findings were consistent with lung 
metastases from hepatic angiosarcoma.
a
b
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likely have been poor. Liver transplantation has also 
been abandoned because of a high recurrence rate and 
poor post-transplantation survival17）.
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